IthaID: 1218
Names and Sequences
Functionality: | Globin gene causative mutation | Pathogenicity: | Pathogenic / Likely Pathogenic |
---|---|---|---|
Common Name: | CD 121 GAA>AAA | HGVS Name: | HBB:c.364G>A |
Hb Name: | Hb O-Arab | Protein Info: | β 121(GH4) Glu>Lys |
Context nucleotide sequence:
TGTGCTGGCCCATCACTTTGGCAAA [G/A] AATTCACCCCACCAGTGCAGGCTGC (Strand: -)
Protein sequence:
MVHLTPEEKSAVTALWGKVNVDEVGGEALGRLLVVYPWTQRFFESFGDLSTPDAVMGNPKVKAHGKKVLGAFSDGLAHLDNLKGTFATLSELHCDKLHVDPENFRLLGNVLVCVLAHHFGKKFTPPVQAAYQKVVAGVANALAHKYH
Also known as: Hb Egypt, Hb O-Thrace
We follow the HGVS sequence variant nomenclature and IUPAC standards.
Phenotype
Hemoglobinopathy Group: | Structural Haemoglobinopathy |
---|---|
Hemoglobinopathy Subgroup: | β-chain variant |
Allele Phenotype: | N/A |
Stability: | N/A |
Oxygen Affinity: | N/A |
Associated Phenotypes: | N/A |
Location
Chromosome: | 11 |
---|---|
Locus: | NG_000007.3 |
Locus Location: | 71938 |
Size: | 1 bp |
Located at: | β |
Specific Location: | Exon 3 |
Other details
Type of Mutation: | Point-Mutation(Substitution) |
---|---|
Effect on Gene/Protein Function: | Missense codons (Protein Structure) |
Ethnic Origin: | African | Arabian | Egyptian | Balkanese |
Molecular mechanism: | N/A |
Inheritance: | Recessive |
DNA Sequence Determined: | Yes |
HPLC
Disclaimer: The HPLC images are provided as an information resource only.
Bio-Rad Laboratories, Inc and the ITHANET Portal disclaim responsibility and have no liability if this information is used for diagnostic or treatment purposes.
D-10™ and VARIANT™ are registered trademarks of Bio-Rad Laboratories, Inc. and used with permission.
Redistribution and use of the above material is allowed only with permission by Bio-Rad Laboratories, Inc.
To access HPLC images and reports for different variants, use the IthaChrom tool.
ID | Hb Variant | Gene | Instrument | Method | Area (%) | Ret Time (min) | Comments | ||
---|---|---|---|---|---|---|---|---|---|
569 | Hb O-Arab | β | D-10 | Dual Kit Program | 41.6 | 4.56 | Compound heterozygosity for HbC and Hb O Arab (extremely rare). This situation is important to be identified for genetic counselling since both alleles when associated to HbS lead to a severe sickle cell syndrome. | [PDF] | |
301 | Hb O-Arab | β | D-10 | Dual Kit Program | 29.4 | 4.57 | Heterozygote, clinically normal. | [PDF] | |
24 | Hb O-Arab | β | D-10 | HbA1c Program | 64.9 | 1.49 | Heterozygous; Heterozygote clinically normal. Homozygote present with a mild microcytic anemia. When associated to HbS leads to a severe sickle cell anemia. | [PDF] | |
571 | Hb O-Arab | β | VARIANT | β-thal Short Program | 44.8 | 4.85 | Compound heterozygosity for HbC and Hb O Arab (extremely rare). This situation is important to be identified for genetic counselling since both alleles when associated to HbS lead to a severe sickle cell syndrome. | [PDF] | |
302 | Hb O-Arab | β | VARIANT | β-thal Short Program | 32.9 | 4.3 | Heterozygote, clinically normal. | [PDF] | |
575 | Hb O-Arab | β | VARIANT II | Dual Kit Program | 42.1 | 3.999 | Compound heterozygosity for HbC and Hb O Arab (extremely rare). This situation is important to be identified for genetic counselling since both alleles when associated to HbS lead to a severe sickle cell syndrome. | [PDF] | |
573 | Hb O-Arab | β | VARIANT II | β-thal Short Program | 46.1 | 4.9 | Compound heterozygosity for HbC and Hb O Arab (extremely rare). This situation is important to be identified for genetic counselling since both alleles when associated to HbS lead to a severe sickle cell syndrome. | [PDF] | |
304 | Hb O-Arab | β | VARIANT II | Dual Kit Program | 30.6 | 4.01 | Heterozygote, clinically normal. | [PDF] | |
303 | Hb O-Arab | β | VARIANT II | β-thal Short Program | 32.3 | 4.91 | Heterozygote, clinically normal. | [PDF] | |
25 | Hb O-Arab | β | VARIANT II | HbA1c Program | 31.3 | 2.02 | Heterozygous; Heterozygote clinically normal. Homozygote present with a mild microcytic anemia. When associated to HbS leads to a severe sickle cell anemia. | [PDF] |
In silico pathogenicity prediction
Note:
The impact thresholds provided in this section are based on the analyses performed in Tamana et.al. For any given tool, the impact thresholds defined for the set of variants with the same effect on function as the variant examined, are preferred over those defined for the full dataset.
Frequencies
Publications / Origin
- Vella F, Beale D, Lehmann H, Haemoglobin O Arab in Sudanese., Nature, 209(5020), 308-9, 1966
- Kantchev KN, Tcholakov BN, Casey R, Lehmann H, El Hazmi M, Twelve families with Hb O Arab in the Burgas district of Bulgaria. Observations on sixteen examples of Hb O Arab-beta (0) thalassaemia., Humangenetik, 26(2), 93-7, 1975
- Efremov GD, Sadikario A, Stojancov A, Dojcinov D, Huisman TH, Homozygous hemoglobin O Arab in a gypsy family in Yugoslavia., Hemoglobin, 1(4), 389-94, 1977
Created on 2010-06-16 16:13:17,
Last reviewed on 2021-03-10 17:38:09 (Show full history)
A/A | Date | Curator(s) | Comments |
---|---|---|---|
1 | 2010-06-16 16:13:17 | The IthaGenes Curation Team | Created |
2 | 2013-10-15 17:00:14 | The IthaGenes Curation Team | Reviewed. |
3 | 2015-06-02 12:19:35 | The IthaGenes Curation Team | Reviewed. |
4 | 2021-03-10 17:38:09 | The IthaGenes Curation Team | Reviewed. References added. |
Disclaimer: The information on this website is provided as an information resource only
and must not to be used as a substitute for professional diagnosis and treatment.
The ITHANET Portal and IthaGenes are not responsible or liable for any advice, course of treatment,
diagnosis or any other information, services or products that an individual obtains through this website.
IthaGenes was last updated on 2024-11-20 13:24:07